Wave Life Sciences Pte Ltd.

General Information

We are a preclinical biopharmaceutical company with an innovative and proprietary synthetic chemistry drug development platform that we are using to design, develop and commercialize a broad pipeline of first-in-class or best-in-class nucleic acid therapeutic candidates. Nucleic acid therapeutics have the potential to address diseases that have been difficult to treat with small molecule drugs or biologics and have emerged as a large and promising class of drugs. We are initially developing nucleic acid therapeutics that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.

Employees: 28
Founded: 2012
Contact Information
Address 8 Cross Street #10-00, PWC Building, Singapore 048424
Phone Number +65 6236 7389
Web Address http://www.wavelifesciences.com
View Prospectus: Wave Life Sciences Pte Ltd.
Financial Information
Market Cap $397.3mil
Revenues $0.0 mil (last 12 months)
Net Income $-10.3 mil (last 12 months)
IPO Profile
Symbol WVE
Exchange NASDAQ
Shares (millions): 6.4
Price range $16.00 - $16.00
Est. $ Volume $102.0 mil
Manager / Joint Managers Jefferies/ Leerink Partners
CO-Managers JMP Securities/ SunTrust Robinson Humphrey
Expected To Trade: 11/11/2015
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change